Sign up
Log in
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Mobile-health Network (NASDAQ:MNDR) shares rose 26.8% to $1.8 during Tuesday's after-market session. The company's market cap stands at $7.8 million.
  • GlucoTrack (NASDAQ:GCTK) stock moved upwards by 17.85% to $0.2. The company's market cap stands at $5.1 million.
  • Aspire Biopharma Hldgs (NASDAQ:ASBP) shares moved upwards by 9.09% to $0.51. The company's market cap stands at $24.8 million.
  • NuCana (NASDAQ:NCNA) stock rose 9.03% to $0.59. The company's market cap stands at $3.5 million.
  • Radiopharm Theranostics (NASDAQ:RADX) stock rose 7.69% to $4.2. The market value of their outstanding shares is at $32.6 million.
  • AEON Biopharma (AMEX:AEON) shares rose 7.29% to $0.44. The company's market cap stands at $4.6 million.

Losers

  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares declined by 17.7% to $0.25 during Tuesday's after-market session. The market value of their outstanding shares is at $3.4 million.
  • Akari Therapeutics (NASDAQ:AKTX) shares decreased by 16.43% to $1.17. The company's market cap stands at $33.7 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 8.38% to $0.2. The market value of their outstanding shares is at $1.4 million.
  • Abpro Hldgs (NASDAQ:ABP) stock decreased by 7.66% to $0.24. The company's market cap stands at $12.5 million.
  • BioCardia (NASDAQ:BCDA) shares declined by 7.55% to $2.82. The market value of their outstanding shares is at $12.9 million.
  • LogicMark (NASDAQ:LGMK) stock declined by 7.37% to $0.02. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.